Keyphrases
Thromboxane A2 (TXA2)
100%
Design Evaluation
100%
Synthetic Evaluation
100%
Biological Evaluation
100%
Bronchial Asthma
57%
Myocardial Infarction
42%
Thromboxane A2 Receptor
42%
Dual Activity
28%
IC50
28%
Platelets
14%
Vascular Smooth muscle Cells
14%
Biological Properties
14%
Cyclooxygenase-1 (COX-1)
14%
Receptor Agonist
14%
Smooth muscle
14%
Bronchial Smooth muscle
14%
U46619
14%
Topical Application
14%
Constrictor
14%
Ovalbumin
14%
Arachidonic Acid
14%
Guinea pig Trachea
14%
Platelet Aggregation
14%
Pharmacological Evaluation
14%
Smooth muscle Cell Proliferation
14%
Left Anterior Descending Coronary Artery
14%
Asthma Model
14%
Thromboxane Synthase
14%
Inducer
14%
Cardiovascular Disease
14%
Guinea pig
14%
Ferric Chloride
14%
Porcine Model
14%
Human Platelets
14%
Sulfonylurea
14%
High Affinity
14%
Nitrobenzene
14%
Prostanoids
14%
Torasemide
14%
Rat Aorta
14%
INIS
design
100%
synthesis
100%
evaluation
100%
molecules
100%
asthma
66%
pathology
50%
muscles
50%
receptors
50%
guinea pigs
33%
iron chlorides
16%
aggregation
16%
nitrobenzene
16%
aorta
16%
trachea
16%
coronaries
16%
drugs
16%
concentration
16%
humans
16%
arteries
16%
cell proliferation
16%
production
16%
ovalbumin
16%
applications
16%
affinity
16%
inhibition
16%
arachidonic acid
16%
myocardial infarction
16%
rats
16%
Medicine and Dentistry
Thromboxane A2
100%
Thromboxane A2 Receptor Blocking Agent
100%
Asthma
66%
Myocardial Infarction
50%
Smooth Muscle
33%
Thromboxane A2 Receptor
33%
Platelet
33%
IC50
33%
Ovalbumin
16%
Cell Proliferation
16%
Torasemide
16%
Arachidonic Acid
16%
Thrombocyte Aggregation
16%
Sulfonylurea
16%
Cardiovascular Disease
16%
Thromboxane A2 Receptor Stimulating Agent
16%
Mediator
16%
Smooth Muscle Cell
16%
Topical Drug Administration
16%
Ferric Chloride
16%
Prostanoid
16%
Left Anterior Descending Coronary Artery
16%
Trachea
16%
Nitrobenzene
16%
Thromboxane Synthase
16%
Prostaglandin Synthase
16%